ASH has developed a shared decision-making tool to support clinicians and patients with immune thrombocytopenia (ITP) in considering initial medication choice.
ASH has developed a shared decision-making tool to support clinicians and patients with Acute Myeloid Leukemia (AML) in planning for post-remission treatment for older adults.
ASH has developed a shared decision-making tool to support clinicians and patients with sickle cell disease (SCD) in considering transplantation as a treatment option.
